Meyer, Steffen,Vlaicu, Philip,Macagno, Annalisa,Peterson, Part,Kisand, Kai
申请号：
AU2015282844
公开号：
AU2015282844A1
申请日:
2015.07.03
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
Provided are novel interleukin-20 (IL-20) binding molecules of human origin, particularly human-derived anti-human IL-20 antibodies as well as IL-20 binding fragments, derivatives and biotechnological derivatives thereof. In addition, pharmaceutical compositions, kits and methods for use in diagnosis and therapy are described. In addition, a cellular enzyme-linked ligand binding assay is described for isolating antibodies and biotechnological derivatives thereof for pharmaceutical use, in particular recombinant human-derived anti-human cytokine antibodies.
